Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01143727 · ClinicalTrials.gov registry record · Phase 4
Enzymatic Versus (vs) Autolytic Debridement of Diabetic Foot Ulcers
A Phase 4 study, sponsored by Healthpoint.
- Completed
- Registry status
- Phase 4
- Development phase
- 20
- Enrollment target
NCT01143727 is a Phase 4 study that has completed, run by Healthpoint. The registered enrollment target is 20 participants.
The verdict
NCT01143727, a Phase 4 study, has completed, sponsored by Healthpoint.
- COMPLETED
- Registry status
- Phase 4
- Development phase
- 20 participants
- Enrollment target
Study Summary
This study compares two standard methods for cleaning the surface of wounds on the feet of patients with diabetes mellitus. The question being asked is whether inflammation of the wound affects the ability of one or both of the methods to work.
Interventions
- DRUG Santyl
- DRUG Tegaderm Hydrogel
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 20 participants |
| Start Date | 2010-07 |
| Est. Completion | 2012-10 |
| Phase | Phase 4 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01143727
The ClinicalTrials.gov registry entry for NCT01143727 describes a study currently listed as completed, categorized as Phase 4. The registered enrollment target is 20 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Healthpoint, which has 25 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Santyl is the first listed.
NCT01143727 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01143727 about?
NCT01143727 is a clinical study titled "Enzymatic Versus (vs) Autolytic Debridement of Diabetic Foot Ulcers". This study compares two standard methods for cleaning the surface of wounds on the feet of patients with diabetes mellitus. The question being asked is whether inflammation of the wound affects the ability of one or both of the methods to work.
What is the current status of trial NCT01143727?
This trial is currently completed. It is a Phase 4 study. The enrollment target is 20 participants. The study started on 2010-07. Estimated completion is 2012-10.
What interventions are being tested in trial NCT01143727?
The interventions under investigation include: Santyl (DRUG), Tegaderm Hydrogel (DRUG).
Who is sponsoring clinical trial NCT01143727?
This trial is sponsored by Healthpoint, which has 25 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.